222 related articles for article (PubMed ID: 32068551)
1. What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
Koh CE; Brown KGM; Steffens D; Young J; Salkeld G; Solomon MJ
Ann Surg; 2022 Jan; 275(1):157-165. PubMed ID: 32068551
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer.
Bhangu A; Ali SM; Darzi A; Brown G; Tekkis P
Colorectal Dis; 2012 Dec; 14(12):1457-66. PubMed ID: 22356246
[TBL] [Abstract][Full Text] [Related]
3. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
[TBL] [Abstract][Full Text] [Related]
4. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
5. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
PelvEx Collaborative
Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
[TBL] [Abstract][Full Text] [Related]
6. The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer.
Alberda WJ; Verhoef C; Schipper ME; Nuyttens JJ; Rothbarth J; de Wilt JH; Burger JW
Dis Colon Rectum; 2015 Jul; 58(7):677-85. PubMed ID: 26200682
[TBL] [Abstract][Full Text] [Related]
7. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD
Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701
[TBL] [Abstract][Full Text] [Related]
8. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
Uehara K; Ito Z; Yoshino Y; Arimoto A; Kato T; Nakamura H; Imagama S; Nishida Y; Nagino M
Eur J Surg Oncol; 2015 Mar; 41(3):413-20. PubMed ID: 25477268
[TBL] [Abstract][Full Text] [Related]
9. Impact of resection margin on outcome in soft-tissue sarcomas of the extremities treated with limb-sparing surgery and postoperative radiotherapy.
Chen CC; Wu YY; Kao JT; Chang CH; Huang SC; Shih HN
World J Surg Oncol; 2024 Apr; 22(1):113. PubMed ID: 38664776
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival.
Sasikumar A; Bhan C; Jenkins JT; Antoniou A; Murphy J
Dis Colon Rectum; 2017 Mar; 60(3):346-352. PubMed ID: 28177998
[TBL] [Abstract][Full Text] [Related]
11. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.
Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT
Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715
[TBL] [Abstract][Full Text] [Related]
12. Effect of Surgery on Health-Related Quality of Life of Patients With Locally Recurrent Rectal Cancer.
Pellino G; Sciaudone G; Candilio G; Selvaggi F
Dis Colon Rectum; 2015 Aug; 58(8):753-61. PubMed ID: 26163954
[TBL] [Abstract][Full Text] [Related]
13. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
14. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
[TBL] [Abstract][Full Text] [Related]
15. Management and prognosis of locally recurrent rectal cancer - A national population-based study.
Westberg K; Palmer G; Hjern F; Johansson H; Holm T; Martling A
Eur J Surg Oncol; 2018 Jan; 44(1):100-107. PubMed ID: 29224985
[TBL] [Abstract][Full Text] [Related]
16. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
18. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer.
Brown WE; Koh CE; Badgery-Parker T; Solomon MJ
Dis Colon Rectum; 2017 Feb; 60(2):144-151. PubMed ID: 28059910
[TBL] [Abstract][Full Text] [Related]
19. Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer.
Aiba T; Uehara K; Tsuyuki Y; Ogura A; Murata Y; Mizuno T; Yamaguchi J; Kokuryo T; Yokoyama Y; Ebata T
Eur J Surg Oncol; 2022 Dec; 48(12):2502-2508. PubMed ID: 35768314
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.
Gould LE; Pring ET; Drami I; Moorghen M; Naghibi M; Jenkins JT; Steele CW; Roxburgh CS
Int J Surg; 2022 Aug; 104():106738. PubMed ID: 35781038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
